switching from compounded tirzepatide to zepbound TrimRX TrimRX | Switching From Zepbound
Description
He is heavily involved in research and academia
Compounded medications are not FDA-evaluated for safety or effectiveness
The IRA, MFN pricing, and FTC enforcement have each materially altered the economics of pharmaceutical pricing in ways that make 2019-vintage competitive models unreliable
Response varied widely: 86% lost at least 5%, 69% lost 10%, half lost 15%, and about one-third lost 20%
